CENTENE CORP (CNC)

Current Report Filed: 2026-04-28

Centene announced Q1 2026 financial results on April 28, 2026, with the full press release attached as Exhibit 99.1, providing investors with detailed operational and earnings performance data.
The 8-K filing is a standard earnings announcement with no material agreements, executive changes, or significant corporate events disclosed, indicating routine quarterly reporting.
As a managed healthcare company, Q1 results would typically reflect key metrics such as membership trends, medical loss ratios, and operational efficiency, though specific numbers are not detailed in this cover filing.

Quarterly Report Filed: 2026-04-28

The filing is dated April 28, 2026 for Q1 2026 (ending March 31, 2026), showing Centene Corp continuing operations as a major managed care provider with exposure to healthcare premium members and service members.
The presence of Magellan Health as a held-for-sale asset (marked as disposal group not discontinued operations) indicates ongoing strategic portfolio management and potential divestiture activity that could impact future revenue composition.
The company maintains a diversified investment portfolio across multiple security types (US Treasuries, corporate bonds, municipal bonds, mortgage-backed securities) with fair value measurements across multiple levels, suggesting active treasury management and strong liquidity position.

Insider Trading Filed: 2026-04-16

The Chief People Officer, Tanya M. McNally, reported selling 964 shares of Centene Corporation (CNC) common stock on April 15, 2026, at a price of $37.26 per share.
After the transaction, McNally continues to beneficially own 127,258 shares, including 112,054 shares from previously granted restricted stock units and performance stock units.
The sale of shares appears to be related to a tax withholding event upon the vesting of the restricted stock units, a common practice for executives to cover tax obligations.

Insider Trading Filed: 2026-03-31

Kenneth Tanji, a director of Centene Corporation, acquired 1,179 shares of common stock on March 31, 2026, increasing his direct beneficial ownership to 7,917 shares, which includes 3,579 shares of restricted stock units subject to vesting requirements.
The transaction suggests that Tanji has confidence in the company's future prospects and is willing to increase his stake in the organization.
Investors should monitor insider trading activities, as they can provide valuable insights into management's perspective on the company's outlook and potential growth opportunities.

Insider Trading Filed: 2026-03-31

Insider Theodore R. Samuels II, a director at Centene Corporation, acquired 943 shares of the company's common stock on March 31, 2026 at $0 per share.
Samuels also owns an additional 32,000 shares of Centene through a family trust, indicating continued confidence in the company's prospects.
The acquisition of nearly 1,000 shares at no cost suggests Samuels may have received the shares as part of a compensation or incentive plan, aligning his interests with those of Centene's shareholders.

Insider Trading Filed: 2026-03-31

The reporting person, Frederick H. Eppinger, acquired 1,690 shares of Centene Corporation (CNC) common stock at $0 per share, increasing their direct beneficial ownership to 362,050.658 shares.
Eppinger holds 5,965 shares of restricted stock units subject to vesting requirements, indicating potential future ownership changes.
The transaction was executed on March 31, 2026, suggesting ongoing insider investment in the company.

Insider Trading Filed: 2026-03-31

Christopher Coughlin, a director of Centene Corporation, acquired 1,140 shares of common stock on March 31, 2026 at no cost, increasing his direct ownership to 14,156.926 shares.
Coughlin also holds an indirect ownership of 30,054 shares through a grantor retained annuity trust, for which he is the sole trustee.
The acquisition of shares by a director suggests potential confidence in the company's future prospects.

Current Report Filed: 2026-03-24